Abbott Laboratories is cited for four key alleged violations related to the production of its Freestyle Libre continuous glucose monitoring devices.

Dr Anne Peters discusses updates in the ADA 2026 Standards of Care in Diabetes, focusing on the use of technology.

DexCom (NasdaqGS:DXCM) is upgrading its Stelo glucose monitoring platform with AI driven features that expand its nutrition ...

The company is hiring sales reps and transitioning staff from its former partner to support launches in Germany, Italy, Spain and Sweden.

In patients with type 1 diabetes, use of continuous glucose monitoring (CGM) devices -- alone or with insulin pumps -- was associated with lower odds of developing diabetic retinopathy and ...

Continuous glucose monitoring (CGM) technology, while very early in its development, has been optimistically extolled in numerous editorial and technical reviews in the medical literature as “the ...

Senseonics is bringing the commercialization and distribution of its continuous glucose monitor products back in-house. The Germantown, MD-based company said it has signed a Memorandum of ...

Medical device maker Medtronic has teamed up with Fitbit to integrate physical activity data with blood glucose levels into one streamlined application. People living with type 2 diabetes who use ...

Apple Watch now supports glucose monitoring via CGMs like Dexcom G7, while Apple continues long-term work on non-invasive blood sugar tracking.

DexCom has barely scratched the surface of its niche in the diabetes market. As a result of industry challenges, the stock's valuation has now come down. But from here, the stock looks well-positioned ...

The medical device specialist lagged the market, and even with a bit of a rebound toward the second half of 2025, shares are ...